title: Human beta-defensins (HBD1 and HBD3) and malignant melanoma susceptibility.
authors.forename: Lara P
authors.initials: LP
authors.lastname: Fernandez
authors.forename: Roger L
authors.initials: RL
authors.lastname: Milne
authors.forename: Guillermo
authors.initials: G
authors.lastname: Pita
authors.forename: Uxua
authors.initials: U
authors.lastname: Floristan
authors.forename: Elena
authors.initials: E
authors.lastname: Sendagorta
authors.forename: Marta
authors.initials: M
authors.lastname: Feito
authors.forename: Jose A
authors.initials: JA
authors.lastname: Aviles
authors.forename: Manuel
authors.initials: M
authors.lastname: Martin-Gonzalez
authors.forename: Pablo
authors.initials: P
authors.lastname: Lázaro
authors.forename: Javier
authors.initials: J
authors.lastname: Benítez
authors.forename: Gloria
authors.initials: G
authors.lastname: Ribas
mesh_terms: D016022:Case-Control Studies; D005838:Genotype; D006801:Humans; D008545:Melanoma / Q000235:genetics* / Q000378:metabolism; D020641:Polymorphism, Single Nucleotide; D012878:Skin Neoplasms / Q000235:genetics* / Q000378:metabolism; D023083:beta-Defensins / Q000235:genetics* / Q000378:metabolism
chemical_list: C406407:DEFB1 protein, human; C422950:DEFB103A protein, human; D023083:beta-Defensins